日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A New Histology-Based Prognostic Index for Acute Lymphoblastic Leukemia: Preliminary Results of the "ALL Urayasu Classification".

急性淋巴细胞白血病新的基于组织学的预后指数:“ALL Urayasu 分类”的初步结果。

Mitsumori Toru, Nitta Hideaki, Takizawa Haruko, Iizuka-Honma Hiroko, Furuya Chiho, Maruo Suiki, Fujishiro Maki, Tomita Shigeki, Hashizume Akane, Sawada Tomohiro, Miyake Kazunori, Okubo Mitsuo, Sekiguchi Yasunobu, Noguchi Masaaki

miR-6516-3p-mediated downregulation of the endogenous MMP-9 inhibitor RECK in mesangial cells might exacerbate lupus nephritis

miR-6516-3p介导的系膜细胞内源性MMP-9抑制剂RECK的下调可能加剧狼疮性肾炎

Tomita, Hiroyuki; Hayakawa, Kunihiro; Ikeda, Keigo; Tsushima, Hiroshi; Shinoura, Marina; Fujishiro, Maki; Kataoka, Yuko; Yamaji, Ken; Takamori, Kenji; Tamura, Naoto; Sekigawa, Iwao; Morimoto, Shinji

BTLA-Expressing Memory B Cells Are Associated with Belimumab-Induced Improvement in Systemic Lupus Erythematosus

表达BTLA的记忆B细胞与贝利木单抗诱导的系统性红斑狼疮改善相关

Nishi, Takuya; Hayakawa, Kunihiro; Ikeda, Keigo; Fujishiro, Maki; Kataoka, Yuko; Yamaji, Ken; Takamori, Kenji; Tamura, Naoto; Sekigawa, Iwao; Morimoto, Shinji

A New Histology-Based Prognostic Index for Acute Myeloid Leukemia: Preliminary Results for the "AML Urayasu Classification".

急性髓系白血病新的基于组织学的预后指数:“AML Urayasu 分类”的初步结果

Mitsumori Toru, Nitta Hideaki, Takizawa Haruko, Iizuka-Honma Hiroko, Furuya Chiho, Fujishiro Maki, Tomita Shigeki, Hashizume Akane, Sawada Tomohiro, Miyake Kazunori, Okubo Mitsuo, Sekiguchi Yasunobu, Ando Miki, Noguchi Masaaki

Exposure of female NZBWF1 mice to imiquimod-induced lupus nephritis at an early age via a unique mechanism that differed from spontaneous onset.

NZBWF1 雌性小鼠在幼年时期通过一种独特的机制暴露于咪喹莫特诱导的狼疮性肾炎,这种机制与自发性发作不同

Hayakawa Kunihiro, Fujishiro Maki, Yoshida Yuko, Kataoka Yuko, Sakuma Shota, Nishi Takuya, Ikeda Keigo, Morimoto Shinji, Takamori Kenji, Sekigawa Iwao

Circulating plasma microRNA profiling in patients with polymyositis/dermatomyositis before and after treatment: miRNA may be associated with polymyositis/dermatomyositis

多发性肌炎/皮肌炎患者治疗前后循环血浆microRNA谱分析:miRNA可能与多发性肌炎/皮肌炎相关

Hirai, Takuya; Ikeda, Keigo; Tsushima, Hiroshi; Fujishiro, Maki; Hayakawa, Kunihiro; Yoshida, Yuko; Morimoto, Shinji; Yamaji, Ken; Takasaki, Yoshinari; Takamori, Kenji; Tamura, Naoto; Sekigawa, Iwao

JAK inhibitor has the amelioration effect in lupus-prone mice: the involvement of IFN signature gene downregulation

JAK抑制剂对易患狼疮的小鼠具有改善作用:IFN特征基因下调参与其中

Ikeda, Keigo; Hayakawa, Kunihiro; Fujishiro, Maki; Kawasaki, Mikiko; Hirai, Takuya; Tsushima, Hiroshi; Miyashita, Tomoko; Suzuki, Satoshi; Morimoto, Shinji; Tamura, Naoto; Takamori, Kenji; Ogawa, Hideoki; Sekigawa, Iwao

Serum proteome analysis in patients with rheumatoid arthritis receiving therapy with tocilizumab: an anti-interleukin-6 receptor antibody.

对接受托珠单抗(一种抗白细胞介素-6受体抗体)治疗的类风湿性关节炎患者进行血清蛋白质组分析

Yanagida Mitsuaki, Kawasaki Mikiko, Fujishiro Maki, Miura Masako, Ikeda Keigo, Nozawa Kazuhisa, Kaneko Hiroshi, Morimoto Shinji, Takasaki Yoshinari, Ogawa Hideoki, Takamori Kenji, Sekigawa Iwao